It’s already the middle of January, so before the new year steadily sets in, we’d like to have a quick look back on the route we just came, not long ago.
Omixon had an amazing and very successful 2014. We launched our brand new product Holotype HLA™, opened first offices in the US, signed contracts with new distributors, grew our revenue, number of colleagues and moved to a new office – but most of all, we have done exactly what we set out for in the last year – supporting developments in science, for the benefit of humanity.
We had a truly exciting year full of events, conferences, news and milestones – and had a great time and a lot of fun with brilliant, dedicated people.
Here’s a glance at the top 10 blog posts in 2014:
- Omixon Launches Holotype HLA™ for NGS-based HLA Genotyping
- Omixon Raises Capital, Launches US Office
- Cancer Biomarkers
- Omixon and CHOP Collaborate on NGS-based HLA Genotyping
- Webinar – rare and Null Allele Detection with HLA Twin™
- Omixon Celebrates a Frighteningly Successful ASHI 2014 in Denver
- Omixon Collaborates with G3 and Genomics England to Validate HLA Genotyping from WGS Data
- Omixon Awarded 100k Genome Research Grant
- Patient Stratification in Clinical Trials
- Omixon Celebrates a Successful EFI 2014
Thank you to our friends, colleagues and partners that have been part of our amazing journey….we wish you the very best of success for 2015, it’s going to be great!
